Pulmonary function in patients with inflammatory bowel disease.

The American journal of gastroenterology ·Vol. 73 ·No. 2 ·1980-02-00 ·Pages 154-6

Eade OE, Smith CL, Alexander JR, Whorwell PJ

Abstract

Pulmonary function has been assessed in 36 outpatients with inflammatory bowel disease. The carbon monoxide transfer factor was found to be significantly reduced in patients as compared with matched controls (P less than 0.01). The reason for this reduction is not clear but it is unlikely to be due to sulfasalazine (Salazosulphapyridine).

MeSH Terms

Adolescent Adult Aged Colitis, Ulcerative/drug therapy,physiopathology Crohn Disease/drug therapy,physiopathology Female Humans Male Middle Aged Pulmonary Diffusing Capacity/drug effects Sulfasalazine/therapeutic use

Chemicals

Sulfasalazine

Authors & Affiliations

4 authors, click to expand affiliations / ORCID

Eade O E

Smith C L

Alexander J R

Whorwell P J

Article Info

Journal

The American journal of gastroenterology

Abbr.

Am J Gastroenterol

ISSN

0002-9270

Published

1980-02-00

Pages

154-6

Language

English

Region

United States

NLM ID

0421030

Subset

External Links

PubMed source View journal details

Analysis Services

Pulmonary function in patients with inflammatory bowel disease.

Contact

WeChat Official Account